Roland Z. Kozlowski
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Roland Z. Kozlowski has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
Dayle S Hogg
Departments of Pharmacology and
3 shared publicationsJohn J Borg
Department of Pharmacology, School of Medical Sciences, University of Bristol, Bristol and
3 shared publicationsAndrew F James
Physiology and Cardiovascular Research Laboratories, School of Medical Sciences, University of Bristol, Bristol, UK
1 shared publicationAndrew R. L. Davies
Department of Pharmacology, School of Medical Sciences, University of Bristol, University Walk, Bristol BS8 1TD, UK
1 shared publicationAndrew R.L Davies
1 shared publicationAndrew W Mulvaney
Dyson Perrins Laboratory, University of Oxford, South Parks Road, Oxford, UK OX1 3QY
1 shared publication
Latest Publications
- 1 December 2004
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1028 (1) , 38-55
Volume-Sensitive Organic Osmolyte/Anion Channels in Cancer: Novel Approaches to Studying Channel Modulation Employing Proteomics Technologies
Key elements of tumor development include proliferation, migration, invasiveness, and angiogenesis. Activation of the volume-sensitive organic osmolyte/anion channel (VSOAC) has been suggested to play a role in all of these processes. VSOACs may therefore represent an important therapeutic target in the etiology of cancer. However, pharmacological inhibitors of VSOAC are nonselective and of low potency, highlighting the importance of identifying novel regulators of the channel. The use of electrophysiological methods coupled with techniques such as pull-down assays, yeast 2-hybrid, and functional protein arrays have already proved valuable in studying protein-protein interactions in a variety of systems. Some of these methods have been used to identify small molecules that modulate the function of other types of ion channels. Given that several proteins have already been identified as putative modulators of VSOACs, proteomics technologies may prove useful in elucidating the molecular identity of VSOACs and helpful in identifying novel modulators of channel function. In this paper, we review the involvement of VSOACs in tumor development processes and its regulation by pharmacological agents and cellular proteins. Proteomic approaches to study protein-protein interactions and how such approaches may be used to study VSOACs are also discussed. We speculate on how modulation of protein-protein interactions may result in the identification of a novel class of compounds for modulating VSOACs.
- 1 December 2004
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1028 (1) , 38-55
Volume-Sensitive Organic Osmolyte/Anion Channels in Cancer: Novel Approaches to Studying Channel Modulation Employing Proteomics Technologies
Key elements of tumor development include proliferation, migration, invasiveness, and angiogenesis. Activation of the volume-sensitive organic osmolyte/anion channel (VSOAC) has been suggested to play a role in all of these processes. VSOACs may therefore represent an important therapeutic target in the etiology of cancer. However, pharmacological inhibitors of VSOAC are nonselective and of low potency, highlighting the importance of identifying novel regulators of the channel. The use of electrophysiological methods coupled with techniques such as pull-down assays, yeast 2-hybrid, and functional protein arrays have already proved valuable in studying protein-protein interactions in a variety of systems. Some of these methods have been used to identify small molecules that modulate the function of other types of ion channels. Given that several proteins have already been identified as putative modulators of VSOACs, proteomics technologies may prove useful in elucidating the molecular identity of VSOACs and helpful in identifying novel modulators of channel function. In this paper, we review the involvement of VSOACs in tumor development processes and its regulation by pharmacological agents and cellular proteins. Proteomic approaches to study protein-protein interactions and how such approaches may be used to study VSOACs are also discussed. We speculate on how modulation of protein-protein interactions may result in the identification of a novel class of compounds for modulating VSOACs.
- 1 March 2004
- Published by Wiley in Clinical and Experimental Pharmacology and Physiology
- Vol. 31 (3) , 134-144
DIFFERENTIAL EFFECTS OF PYRETHROIDS ON VOLUME-SENSITIVE ANION AND ORGANIC OSMOLYTE PATHWAYS
1. There are no effective ways of screening for potential modulators of volume-regulated anion channels in their native cell type. Generally, cell lines are used for this purpose. Using HeLa and C6 glioma cells, we identified the pyrethroids as a novel class of compounds that inhibit taurine efflux through volume-regulated anion transport pathways in these cells. Subsequently, we examined their effects on volume-regulated anion channels in guinea-pig ventricular myocytes to determine whether results obtained using cell lines could be extrapolated to other tissues. 2. Tetramethrin inhibited taurine efflux in both HeLa and C6 glioma cells with Ki values of approximately 26 and 16 micro mol/L, respectively. Bioallethrin and fenpropathrin inhibited volume-sensitive taurine efflux from C6 glioma cells, but not from HeLa cells. The Ki values for bioallethrin and fenpropathrin were 70 and 59 micro mol/L, respectively. 3. Volume-sensitive I- efflux was observed in HeLa cells but not in C6 glioma cells, suggesting that the taurine efflux pathway in C6 glioma cells may be different to that of the I- efflux pathway. Cyfluthrin, tetramethrin, fenpropathrin, tefluthrin and bioallethrin all significantly inhibited volume-sensitive I- efflux from HeLa cells at 100 micro mol/L. 4. Patch-clamp experiments have shown inhibition of ICl,vol in guinea-pig ventricular myocytes by fenpropathrin, but not tetramethrin or cypermethrin, at 100 micro mol/L. This revealed that further differences exist between ICl,vol in guinea-pig ventricular myocytes and the anion transport pathways in C6 glioma and HeLa cells. 5. In conclusion, we have shown that pyrethroids differentially inhibit volume-regulated anion and taurine efflux in a number of cell types. Because these compounds have different effects in different cells, it is likely that: (i) more than one pathway is involved in the volume-sensitive transport of anions and organic osmolytes; and (ii) the molecular identities of the channels underlying anion transport are different. Finally, for the reasons given above, care should be taken when extrapolating data from one cell type to another. However, in the absence of an existing high-throughput screen, taurine efflux still represents a viable route for the identification of potential modulators of volume-regulated ion channels.
- 1 March 2004
- Published by Wiley in Clinical and Experimental Pharmacology and Physiology
- Vol. 31 (3) , 134-144
DIFFERENTIAL EFFECTS OF PYRETHROIDS ON VOLUME-SENSITIVE ANION AND ORGANIC OSMOLYTE PATHWAYS
1. There are no effective ways of screening for potential modulators of volume-regulated anion channels in their native cell type. Generally, cell lines are used for this purpose. Using HeLa and C6 glioma cells, we identified the pyrethroids as a novel class of compounds that inhibit taurine efflux through volume-regulated anion transport pathways in these cells. Subsequently, we examined their effects on volume-regulated anion channels in guinea-pig ventricular myocytes to determine whether results obtained using cell lines could be extrapolated to other tissues. 2. Tetramethrin inhibited taurine efflux in both HeLa and C6 glioma cells with Ki values of approximately 26 and 16 micro mol/L, respectively. Bioallethrin and fenpropathrin inhibited volume-sensitive taurine efflux from C6 glioma cells, but not from HeLa cells. The Ki values for bioallethrin and fenpropathrin were 70 and 59 micro mol/L, respectively. 3. Volume-sensitive I- efflux was observed in HeLa cells but not in C6 glioma cells, suggesting that the taurine efflux pathway in C6 glioma cells may be different to that of the I- efflux pathway. Cyfluthrin, tetramethrin, fenpropathrin, tefluthrin and bioallethrin all significantly inhibited volume-sensitive I- efflux from HeLa cells at 100 micro mol/L. 4. Patch-clamp experiments have shown inhibition of ICl,vol in guinea-pig ventricular myocytes by fenpropathrin, but not tetramethrin or cypermethrin, at 100 micro mol/L. This revealed that further differences exist between ICl,vol in guinea-pig ventricular myocytes and the anion transport pathways in C6 glioma and HeLa cells. 5. In conclusion, we have shown that pyrethroids differentially inhibit volume-regulated anion and taurine efflux in a number of cell types. Because these compounds have different effects in different cells, it is likely that: (i) more than one pathway is involved in the volume-sensitive transport of anions and organic osmolytes; and (ii) the molecular identities of the channels underlying anion transport are different. Finally, for the reasons given above, care should be taken when extrapolating data from one cell type to another. However, in the absence of an existing high-throughput screen, taurine efflux still represents a viable route for the identification of potential modulators of volume-regulated ion channels.
- 1 January 2004
- Published by Wiley in Clinical and Experimental Pharmacology and Physiology
- Vol. 31 (1) , 86-95
Actions of the anti-oestrogen agent clomiphene on outward K+ currents in rat ventricular myocytes.
- 1 January 2004
- Published by Wiley in Clinical and Experimental Pharmacology and Physiology
- Vol. 31 (1) , 86-95
Actions of the anti-oestrogen agent clomiphene on outward K+ currents in rat ventricular myocytes.
- 8 August 2003
- Published by Elsevier in European Journal of Pharmacology
- Vol. 474 (2-3) , 185-193
Newly identified structurally disparate modulators of osmosensitive taurine efflux inhibit cell cycle progression
- 8 August 2003
- Published by Elsevier in European Journal of Pharmacology
- Vol. 474 (2-3) , 185-193
Newly identified structurally disparate modulators of osmosensitive taurine efflux inhibit cell cycle progression
- Open Access
- 1 August 2002
- Published by Oxford University Press (OUP) in Cardiovascular Research
- Vol. 55 (2) , 349-360
KV2.1 channels mediate hypoxic inhibition of IKV in native pulmonary arterial smooth muscle cells of the rat
Objective: To determine whether, in native pulmonary arterial smooth muscle cells (PASMC), KV2.1 delayed-rectifying K+ channels are central to the process of hypoxic pulmonary vasoconstriction. Methods: In this study, we tested for the presence of KV2.1 channel transcripts in rat small pulmonary arteries using RT-PCR, and for the protein itself using immunolocalisation. The contribution of KV2.1 channels to whole-cell KV currents ( I KV) and their role in hypoxic inhibition of I KV in native PASMC was investigated utilising patch-clamp recordings. Results: KV2.1 mRNA expression and AbKV2.1 (anti-KV2.1 antibody) protein immunoreactivity were both present in small pulmonary arteries. Dialysis of PASMC with AbKV2.1 significantly attenuated I KV by 67% at +50 mV. Hypoxia (∼20–30 mmHg) inhibited I KV by ∼70% at +50 mV. Ablation of currents associated with KV2.1 using AbKV2.1 caused a marked reduction in the amplitude of I KV. Hypoxia in the presence of the antibody did not affect the magnitude of I KV. Conclusions: These results indicate that KV2.1 channel subunits exist within small pulmonary arteries and conduct a significant part of I KV within native PASMC. Furthermore, application of AbKV2.1 abolishes hypoxic inhibition of I KV in native PASMC suggesting that KV2.1 channels play a pivotal role in mediating hypoxic pulmonary vasoconstriction.
- 1 August 2002
- Published by Oxford University Press (OUP) in Cardiovascular Research
- Vol. 55 (2) , 349-360
Open AccessKV2.1 channels mediate hypoxic inhibition of IKV in native pulmonary arterial smooth muscle cells of the rat
Objective: To determine whether, in native pulmonary arterial smooth muscle cells (PASMC), KV2.1 delayed-rectifying K+ channels are central to the process of hypoxic pulmonary vasoconstriction. Methods: In this study, we tested for the presence of KV2.1 channel transcripts in rat small pulmonary arteries using RT-PCR, and for the protein itself using immunolocalisation. The contribution of KV2.1 channels to whole-cell KV currents ( I KV) and their role in hypoxic inhibition of I KV in native PASMC was investigated utilising patch-clamp recordings. Results: KV2.1 mRNA expression and AbKV2.1 (anti-KV2.1 antibody) protein immunoreactivity were both present in small pulmonary arteries. Dialysis of PASMC with AbKV2.1 significantly attenuated I KV by 67% at +50 mV. Hypoxia (∼20–30 mmHg) inhibited I KV by ∼70% at +50 mV. Ablation of currents associated with KV2.1 using AbKV2.1 caused a marked reduction in the amplitude of I KV. Hypoxia in the presence of the antibody did not affect the magnitude of I KV. Conclusions: These results indicate that KV2.1 channel subunits exist within small pulmonary arteries and conduct a significant part of I KV within native PASMC. Furthermore, application of AbKV2.1 abolishes hypoxic inhibition of I KV in native PASMC suggesting that KV2.1 channels play a pivotal role in mediating hypoxic pulmonary vasoconstriction.
- Open Access
- 9 June 2002
- Published by Wiley in FEBS Letters
- Vol. 522 (1-3) , 125-129
Hypoxia activates a background conductance in freshly isolated pulmonary arterial endothelial cells of the rat
Utilising the patch‐clamp recording technique we have demonstrated for the first time the effects of hypoxia on the background current in pulmonary arterial endothelial cells. Electrophysiological studies revealed the presence of a novel oxygen‐sensitive, non‐selective cation conductance (I NSC) in these cells. The inward component of I NSC was significantly potentiated by hypoxia. Both the inward and outward components of I NSC were inhibited by both La3+ and Gd3+. Hypoxic activation of I NSC may provide an important Ca2+ influx pathway essential for the release of a pulmonary‐selective vasoconstrictor pivotal to the sustained phase of hypoxic pulmonary vasoconstriction.
- 9 June 2002
- Published by Wiley in FEBS Letters
- Vol. 522 (1-3) , 125-129
Open AccessHypoxia activates a background conductance in freshly isolated pulmonary arterial endothelial cells of the rat
Utilising the patch‐clamp recording technique we have demonstrated for the first time the effects of hypoxia on the background current in pulmonary arterial endothelial cells. Electrophysiological studies revealed the presence of a novel oxygen‐sensitive, non‐selective cation conductance (I NSC) in these cells. The inward component of I NSC was significantly potentiated by hypoxia. Both the inward and outward components of I NSC were inhibited by both La3+ and Gd3+. Hypoxic activation of I NSC may provide an important Ca2+ influx pathway essential for the release of a pulmonary‐selective vasoconstrictor pivotal to the sustained phase of hypoxic pulmonary vasoconstriction.
- 29 January 2001
- Published by Elsevier in Drug Discovery Today
- Vol. 6 (1) , 19-20
Open day review: bridging the gap between academia and industry
- 29 January 2001
- Published by Elsevier in Drug Discovery Today
- Vol. 6 (1) , 19-20
Open day review: bridging the gap between academia and industry
- 1 November 2000
- Published by Elsevier in Drug Discovery Today
- Vol. 5 (11) , 492-505
Cardiac chloride channels: physiology, pharmacology and approaches for identifying novel modulators of activity
- 1 November 2000
- Published by Elsevier in Drug Discovery Today
- Vol. 5 (11) , 492-505
Cardiac chloride channels: physiology, pharmacology and approaches for identifying novel modulators of activity
- 1 June 2000
- Published by Wiley in British Journal of Pharmacology
- Vol. 130 (4) , 787-796
Electrophysiological effects of endothelin‐1 and their relationship to contraction in rat renal arterial smooth muscle
The electophysiological effects of endothelin‐1 (ET‐1) and their relationship to contraction remain unclear in the renal circulation. Using endotheliumdenuded arteries from the main branch of the renal artery proximal to the kidney of the rat, we have examined its effects on tension and conducted parallel patch‐clamp measurements using freshly isolated smooth muscle cells from this tissue. Pharmacological experiments revealed that ET‐1 produced constriction of renal arteries dependent on the influx of extracellular Ca2+, mediated solely through ETA receptor stimulation. Current‐clamp experiments revealed that renal arterial myocytes had a resting membrane potential of ∼32 mV, with the majority of cells exhibiting spontaneous transient hyperpolarizations (STHPs). Application of ET‐1 produced depolarization and in those cells exhibiting STHPs, either caused their inhibition or made them occur regularly. Under voltage‐clamp conditions cells were observed to exhibit spontaneous transient outward currents (STOCs) inhibited by iberiotoxin. Application of voltage‐ramps revealed an outward current activated at ∼−30 mV, sensitive to both 4‐AP and TEA. Taken together these results suggest that renal arterial myocytes possess both delayed rectifying K+ (KV) and Ca2+‐activated K+ (BKCa) channels. Under voltage‐clamp, ET‐1 attenuated the outward current and reduced the magnitude and incidence of STOCs: effects mediated solely as a consequence of ETA receptor stimulation. Thus, in conclusion, activation of ETA receptors by ET‐1 causes inhibition of KV and BKCa channel activity, which could promote and/or maintain membrane depolarization. This effect is likely to favour L‐type Ca2+ channel activity providing an influx pathway for extracellular Ca2+ essential for contraction. British Journal of Pharmacology (2000) 130, 787–796; doi:10.1038/sj.bjp.0703377
- 1 June 2000
- Published by Wiley in British Journal of Pharmacology
- Vol. 130 (4) , 787-796
Electrophysiological effects of endothelin‐1 and their relationship to contraction in rat renal arterial smooth muscle
The electophysiological effects of endothelin‐1 (ET‐1) and their relationship to contraction remain unclear in the renal circulation. Using endotheliumdenuded arteries from the main branch of the renal artery proximal to the kidney of the rat, we have examined its effects on tension and conducted parallel patch‐clamp measurements using freshly isolated smooth muscle cells from this tissue. Pharmacological experiments revealed that ET‐1 produced constriction of renal arteries dependent on the influx of extracellular Ca2+, mediated solely through ETA receptor stimulation. Current‐clamp experiments revealed that renal arterial myocytes had a resting membrane potential of ∼32 mV, with the majority of cells exhibiting spontaneous transient hyperpolarizations (STHPs). Application of ET‐1 produced depolarization and in those cells exhibiting STHPs, either caused their inhibition or made them occur regularly. Under voltage‐clamp conditions cells were observed to exhibit spontaneous transient outward currents (STOCs) inhibited by iberiotoxin. Application of voltage‐ramps revealed an outward current activated at ∼−30 mV, sensitive to both 4‐AP and TEA. Taken together these results suggest that renal arterial myocytes possess both delayed rectifying K+ (KV) and Ca2+‐activated K+ (BKCa) channels. Under voltage‐clamp, ET‐1 attenuated the outward current and reduced the magnitude and incidence of STOCs: effects mediated solely as a consequence of ETA receptor stimulation. Thus, in conclusion, activation of ETA receptors by ET‐1 causes inhibition of KV and BKCa channel activity, which could promote and/or maintain membrane depolarization. This effect is likely to favour L‐type Ca2+ channel activity providing an influx pathway for extracellular Ca2+ essential for contraction. British Journal of Pharmacology (2000) 130, 787–796; doi:10.1038/sj.bjp.0703377
- 30 January 2000
- Published by Wiley in British Journal of Pharmacology
- Vol. 129 (2) , 235-238
A novel anionic conductance affects action potential duration in isolated rat ventricular myocytes
Effects of extracellular anions were studied in electrophysiological experiments on freshly isolated rat ventricular myocytes. Under current‐clamp, action potential duration (APD) was prolonged by reducing the extracellular Cl− concentration and shortened by replacement of extracellular Cl− with I−. Under voltage‐clamp, membrane potential steps or ramps evoked an anionic background current (IAB) carried by either Cl−, Br−, I− or NO3−. Activation of IAB was Ca2+‐ and cyclic AMP‐independent, and was unaffected by cell shrinkage. IAB was insensitive to stilbene and fenamate anion transport blockers at concentrations that inhibit Ca2+‐, cyclic AMP‐ and swelling‐activated Cl− currents in ventricular cells of other mammals. These results suggest that IAB may be carried by a novel class of Cl− channel. Correlation of anion substitution experiments on membrane current and action potentials revealed that IAB could play a major role in controlling rat ventricular APD. These findings have important implications for those studying cardiac Cl− channels as potential targets for novel antiarrythmic agents.British Journal of Pharmacology (2000) 129, 235–238; doi:10.1038/sj.bjp.0703074
- 30 January 2000
- Published by Wiley in British Journal of Pharmacology
- Vol. 129 (2) , 235-238
A novel anionic conductance affects action potential duration in isolated rat ventricular myocytes
Effects of extracellular anions were studied in electrophysiological experiments on freshly isolated rat ventricular myocytes. Under current‐clamp, action potential duration (APD) was prolonged by reducing the extracellular Cl− concentration and shortened by replacement of extracellular Cl− with I−. Under voltage‐clamp, membrane potential steps or ramps evoked an anionic background current (IAB) carried by either Cl−, Br−, I− or NO3−. Activation of IAB was Ca2+‐ and cyclic AMP‐independent, and was unaffected by cell shrinkage. IAB was insensitive to stilbene and fenamate anion transport blockers at concentrations that inhibit Ca2+‐, cyclic AMP‐ and swelling‐activated Cl− currents in ventricular cells of other mammals. These results suggest that IAB may be carried by a novel class of Cl− channel. Correlation of anion substitution experiments on membrane current and action potentials revealed that IAB could play a major role in controlling rat ventricular APD. These findings have important implications for those studying cardiac Cl− channels as potential targets for novel antiarrythmic agents.British Journal of Pharmacology (2000) 129, 235–238; doi:10.1038/sj.bjp.0703074